1. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.
- Author
-
Veyrat M, Durand S, Classe M, Glavan TM, Oker N, Kapetanakis NI, Jiang X, Gelin A, Herman P, Casiraghi O, Zagzag D, Enot D, Busson P, and Vérillaud B
- Subjects
- Antigens, Neoplasm metabolism, Carbonic Anhydrase IX metabolism, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell pathology, Cell Line, Tumor, Cell Proliferation drug effects, Citric Acid Cycle drug effects, Glycolysis drug effects, Head and Neck Neoplasms genetics, Head and Neck Neoplasms pathology, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Oxidative Phosphorylation drug effects, RNA Interference, Signal Transduction drug effects, Squamous Cell Carcinoma of Head and Neck, Time Factors, Toll-Like Receptor 3 genetics, Toll-Like Receptor 3 metabolism, Transfection, Tumor Hypoxia, Carcinoma, Squamous Cell metabolism, Cellular Reprogramming drug effects, Energy Metabolism drug effects, Head and Neck Neoplasms metabolism, Poly A-U pharmacology, Toll-Like Receptor 3 agonists
- Abstract
In this study, a possible link between the innate immune recognition receptor TLR3 and metabolic reprogramming in Head and Neck carcinoma (HNC) cells was investigated. The effects of TLR3 stimulation/knock-down were assessed under several culture conditions in 4 HNC cell-lines by cell growth assays, targeted metabolomics, and glycolysis assays based on time-resolved analysis of proton release (Seahorse analyzer). The stimulation of TLR3 by its synthetic agonist Poly(A:U) resulted in a faster growth of HNC cells under low foetal calf serum conditions. Targeted analysis of glucose metabolism pathways demonstrated a tendency towards a shift from tricarboxylic acid cycle (Krebs cycle) to glycolysis and anabolic reactions in cells treated with Poly(A:U). Glycolysis assays confirmed that TLR3 stimulation enhanced the capacity of malignant cells to switch from oxidative phosphorylation to extra-mitochondrial glycolysis. We found evidence that HIF-1α is involved in this process: addition of the TLR3 agonist resulted in a higher cell concentration of the HIF-1α protein, even in normoxia, whereas knocking-down TLR3 resulted in a lower concentration, even in hypoxia. Finally, we assessed TLR3 expression by immunohistochemistry in a series of 7 HNSCC specimens and found that TLR3 was detected at higher levels in tumors displaying a hypoxic staining pattern. Overall, our results demonstrate that TLR3 stimulation induces the Warburg effect in HNC cells in vitro, and suggest that TLR3 may play a role in tumor adaptation to hypoxia.
- Published
- 2016
- Full Text
- View/download PDF